Corporate Member News

Health Catalyst Secures up to $100 Million with Financing Led By OrbiMed

Health Catalyst, Inc., a leader in next-generation data, analytics and improvement, announced the closing of a Series F equity and debt funding round led by OrbiMed, a leading healthcare public and private market investment firm. This equity and debt funding will provide Health Catalyst with access to up to $100 million in capital.  Several existing investors including Sequoia Capital, Norwest Venture Partners, Sands Capital Ventures, UPMC Enterprises and Kaiser Permanente Ventures also contributed to the financing, which lifts Health Catalyst’s value above $1 billion.

 

Click for Full Release